Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35245482)

  • 1. Combined metabolomics with transcriptomics reveals potential plasma biomarkers correlated with non-small-cell lung cancer proliferation through the Akt pathway.
    Zheng J; Zheng Y; Li W; Zhi J; Huang X; Zhu W; Liu Z; Gong L
    Clin Chim Acta; 2022 May; 530():66-73. PubMed ID: 35245482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker identification and pathway analysis of rheumatoid arthritis based on metabolomics in combination with ingenuity pathway analysis.
    He Z; Liu Z; Gong L
    Proteomics; 2021 Jun; 21(11-12):e2100037. PubMed ID: 33969925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Metabolomics with Transcriptomics Reveals Important Serum Biomarkers Correlated with Lung Cancer Proliferation through a Calcium Signaling Pathway.
    Zheng Y; He Z; Kong Y; Huang X; Zhu W; Liu Z; Gong L
    J Proteome Res; 2021 Jul; 20(7):3444-3454. PubMed ID: 34056907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum untargeted metabolomics reveal metabolic alteration of non-small cell lung cancer and refine disease detection.
    Li J; Liu K; Ji Z; Wang Y; Yin T; Long T; Shen Y; Cheng L
    Cancer Sci; 2023 Feb; 114(2):680-689. PubMed ID: 36310111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortisol, cortisone, and 4-methoxyphenylacetic acid as potential plasma biomarkers for early detection of non-small cell lung cancer.
    Xiang C; Jin S; Zhang J; Chen M; Xia Y; Shu Y; Guo R
    Int J Biol Markers; 2018 Aug; 33(3):314-320. PubMed ID: 29896992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on plasma amino acids and piperonamide as potential diagnostic biomarkers of non-small cell lung cancer.
    Zhang C; Wang Y; Cao Y; Shi L; Wang R; Sheng N; Wang Q; Zhu Z
    Transl Cancer Res; 2022 May; 11(5):1269-1284. PubMed ID: 35706818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma metabolomics for the assessment of the progression of non-small cell lung cancer.
    Zhang Y; Cheng Y; Qin L; Liu Y; Huang S; Dai L; Tao J; Pan J; Su C; Zhang Y
    Int J Biol Markers; 2023 Mar; 38(1):37-45. PubMed ID: 36377344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study identifying a potential plasma biomarker for determining EGFR mutations in exons 19 or 21 in lung cancer patients.
    Pamungkas AD; Medriano CA; Sim E; Lee S; Park YH
    Mol Med Rep; 2017 Jun; 15(6):4155-4161. PubMed ID: 28487968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
    Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
    Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of metabolomics and machine learning revealed tryptophan metabolites are sensitive biomarkers of pemetrexed efficacy in non-small cell lung cancer.
    Sun R; Fei F; Wang M; Jiang J; Yang G; Yang N; Jin D; Xu Z; Cao B; Li J
    Cancer Med; 2023 Sep; 12(18):19245-19259. PubMed ID: 37605514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
    Shang X; Zhong X; Tian X
    Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive analysis of metabolomics and transcriptomics in non-small cell lung cancer.
    Ruiying C; Zeyun L; Yongliang Y; Zijia Z; Ji Z; Xin T; Xiaojian Z
    PLoS One; 2020; 15(5):e0232272. PubMed ID: 32374740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dramatically changed immune-related molecules as early diagnostic biomarkers of non-small cell lung cancer.
    Ye X; Zhang N; Jin Y; Xu B; Guo C; Wang X; Su Y; Yang Q; Song J; Yu W; Cheng P; Cheng L; Gong Y; Fu X; Sun H
    FEBS J; 2020 Feb; 287(4):783-799. PubMed ID: 31482685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer detection using targeted plasma metabolomics.
    Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
    Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
    BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
    Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
    Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined analysis of gut microbiome and serum metabolomics reveals novel biomarkers in patients with early-stage non-small cell lung cancer.
    Ni B; Kong X; Yan Y; Fu B; Zhou F; Xu S
    Front Cell Infect Microbiol; 2023; 13():1091825. PubMed ID: 36743312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid Chromatography-Mass Spectrometry-Based Tissue Metabolic Profiling Reveals Major Metabolic Pathway Alterations and Potential Biomarkers of Lung Cancer.
    You L; Fan Y; Liu X; Shao S; Guo L; Noreldeen HAA; Li Z; Ouyang Y; Li E; Pan X; Liu T; Tian X; Ye F; Li X; Xu G
    J Proteome Res; 2020 Sep; 19(9):3750-3760. PubMed ID: 32693607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study.
    Maeda J; Higashiyama M; Imaizumi A; Nakayama T; Yamamoto H; Daimon T; Yamakado M; Imamura F; Kodama K
    BMC Cancer; 2010 Dec; 10():690. PubMed ID: 21176209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.